Abiopharma

Trustee’s report for BONDS Series 3 of Equital Ltd. for 2026, Strauss Lazar

The interest on commercial papers (series 6) for the period 12.6.25–10.6.26 is 4.6493%

AI Speeds Up Returns in Private Equity as M&A Becomes Top Value Generator for Firms

Shareholders register, changes and capital status – expansion of BONDS (series 13 and 14) – supplementary report

Change in holdings of interested parties/officers - Shmuel Shilo

Autonomix Medical Highlights Clinical Data Presented at Society of Surgical Oncology Annual Meeting in Virtual Investor "What This Means" Segment Featuring City of Hope Chief of Medicine

Cheetah Mobile To Report First Quarter 2026 Financial Results on June 10, 2026

Asana Unveils Operating System for Human-Agent Teams

Sportradar Nets Official Wimbledon Tennis Data and AV Betting Rights Deal

Communiqué de presse : Sanofi lance son plan mondial 2026 d’actionnariat salarié